Shon GreenSenior Director, Translational Sciences at Umoja Biopharma
Dr. Green trained at UC Berkeley and UCSF where she developed preclinical models of cancer to study tumor biology and combinatorial therapeutic approaches. She utilized these expertise to drive the preclinical development of T cell-based immunotherapies targeting both solid and liquid tumors at Eureka Therapeutics Inc. (Emeryville, CA), where she successfully guided two novel programs through preclinical proof-of-concept and safety studies to support investigational new drug applications and clinical testing. She was then recruited to direct the development and clinical translation of novel genome engineering tools to enhance cellular therapies for cancer at Altius Institute for Biomedical Sciences (Seattle, WA). Now at Umoja Biopharma, she is leading the translational R&D strategy to obtain proof-of-concept for potentially disruptive new approaches to cancer immunotherapy.